A 48-year-old woman developed QT prolongation and episodes of life-threatening ventricular tachycardia (torsades de pointes) after intentional overdose of haloperidol and orphenadrine. The arrhythmia did not respond to conventional anti-arrhythmic therapy but was suppressed by atrial overdrive pacing. A literature review identified haloperidol as the most likely cause of the torsades de pointes.
Get full access to this article
View all access options for this article.
References
1.
Krikler DM & Curry Pvl.Torsades de pointes, an atypical ventricular tachycardia. British Heart Journal1976; 38: 117-20.
2.
Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW & Waldo ALTorsades de pointes: the long-short initiating sequence and other clinical features: observation in 32 patients. Journal ofthe American College of Cardiology1983; 2: 806-17.
3.
Tzivoni D., Keren A. & Stern S.Torsades de pointes versus polymorphous ventricular tachycardia. American Journal of Cardiology1983; 52: 639-40.
4.
Zee-Cheng CS , Mueller CE, Seifert CF & Gibbs HRHaloperidol and torsades de pointes. Annals of Internal Medicine1985; 102: 418.
5.
Fayer SATorsades de pointes ventricular tachyarrhythmia associated with haloperidol . Journal of Clinical Psychopharmacology1986 ; 6: 375-6.
6.
Mehta D., Mehta S., Petit J. & Shriner W.Cardiac arrhythmia and haloperidol. American Journal of Psychiatry1979; 136: 1468.
7.
Bett Jhn & Holt GWMalignant ventricular tachycardia and haloperidol. British Medical Journal1983; 287: 1264.
8.
Snyder BD, Kane M. & Plocher D.Orphenadrine overdose treated with physostigmine. New England Journal of Medicine1976; 295: 1435.
9.
Bennett MB & Kohn J.Case report: orphenadrine overdose. Cerebral manifestation treated with physostigmine . Anaesthesia and Intensive Care1976; 4:67.
10.
Sangster B. , Van Heijst Anp, Zimmerman Ane & De Vries HWIntoxication by orphenadrine HCl; mechanism and therapy. Acta Phamacologica et Toxicologica1977; 41 (suppl 2): 129-36.
11.
Bozza-Marrubini M., Frigerio A., Ghezzi R. et al. Two cases of severe orphenadrine poisoning with atypical features. Acta Pharmacologica et Toxicologica1977; 41 (suppl 2): 137-52.
12.
Heinonen J. , Heikkila J., Mattila MJ & Takki S.Orphenadrine poisoning. A case supplemented with animal experiments. Archiv für Toxikologie1968; 23: 264-72.
13.
Stoddart JC , Parkin JM & Wynne NAOrphenadrine poisoning . British Journal of Anaesthesia1968; 40: 789-90.
14.
Millar WMDeaths after overdoses of orphenadrine. Lancet1977; ii: 566.
15.
Clarke B., Mair J. & Rudolf M.Acute poisoning with orphenadrine. Lancet1985; i: 1386.
16.
Doenecke Al & Heuermann RCTreatment of haloperidol abuse with diphenhydramine . American Journal of Psychiatry1980; 137: 487-8.
